Catestatin vs Vasostatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Catestatin is a 21-amino acid peptide derived from the chromogranin A (CgA) protein, specifically cleaved from the region spanning residues 352-372. It was identified as an endogenous inhibitor of catecholamine secretion, acting as a non-competitive antagonist at nicotinic acetyl...
Calculate Catestatin dose →Vasostatin refers to the N-terminal fragments of chromogranin A (CgA), particularly CgA1-76 (Vasostatin-1) and CgA1-113 (Vasostatin-2), generated by proteolytic processing of the chromogranin A precursor. While catestatin (CgA352-372) is the C-terminal CgA fragment with anti-cate...
Calculate Vasostatin dose →| Parameter | Catestatin | Vasostatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical / Early Human | Preclinical Research |
| Half-Life | ~15-30 minutes (IV) | ~20-30 minutes (estimated) |
| Typical Dose | 0.3-3 nmol/kg (animal studies) | 0.1-10 nmol/kg IV (animal) |
| Frequency | Acute dosing in research | Acute dosing |
| Route | IV (research); intranasal under study | IV (research) |
| FDA Status | Research compound | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.